Charles G. Theillet

机构：Centre National de la Recherche Scientifique, Inserm, University of Toronto, Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier · ORCID：0000-0001-5555-2759

发表论文 264 篇 · 总被引 12251 次 · h-index 63

代表论文

CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast Cancer (2024 · Cancer Letters · 被引 26)
Prognostic Value of Trop‐2 Expression in Nonmetastatic Triple‐Negative Breast Cancer and Correlation With Emerging Biomarkers (2025 · Cancer Medicine · 被引 8)
Replication-Poison Treatment in BRCA1 -Deficient Breast Cancer Causes MRE11 Over-Resection That Induces Single-Stranded DNA Accumulation and Mitotic Catastrophe (2025 · Cancer Research · 被引 3)
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy (2026 · Cancer Treatment Reviews · 被引 2)
Mechanisms for stroma-induced secondary chemoresistance in pancreatic adenocarcinoma (2025 · Pancreatology)
Supplementary Data from Replication-Poison Treatment in BRCA1-Deficient Breast Cancer Causes MRE11 Over-Resection That Induces Single-Stranded DNA Accumulation and Mitotic Catastrophe (2025)